Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MED21 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA553559
Description
Immunogen sequence: DAVNSLADQF CNAIGVLQQC GPPASFNNIQ TAINKDQPAN PTEEYAQLFA ALIARTAKDI DVLIDSLPSE ESTAALQAAS LYKLEEENHE AATCLEDVVY RGDMLLEKIQ SALADIAQSQ Highest antigen sequence identity to the following orthologs: Mouse - 99%, Rat - 99%.
This gene encodes a member of the mediator complex subunit 21 family. The encoded protein interacts with the human RNA polymerase II holoenzyme and is involved in transcriptional regulation of RNA polymerase II transcribed genes. A pseudogene of this gene is located on chromosome 8. Alternative splicing results in multiple transcript variants.
Specifications
MED21 | |
Polyclonal | |
Unconjugated | |
MED21 | |
0610007L03Rik; AI449604; D19234; D6Ertd782e; fk48d02; hSrb7; hypothetical protein LOC539496; MED21; Mediator complex subunit 21; mediator of RNA polymerase II transcription subunit 21; RNA polymerase II holoenzyme component SRB7; RNAPII complex component SRB7; si:ch211-203h15.4; SRB7; SRB7 (supressor of RNA polymerase B) homolog; SRB7 suppressor of RNA polymerase B homolog; surb7; wu:fk48d02; zgc:56532 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
9412 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q13503 | |
MED21 | |
Recombinant protein corresponding to Human MED21. Recombinant protein control fragment (Product #RP-89366). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction